Your browser doesn't support javascript.
loading
CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells.
Kozlova, Veronika; Ledererova, Aneta; Ladungova, Adriana; Peschelova, Helena; Janovska, Pavlina; Slusarczyk, Aleksander; Domagala, Joanna; Kopcil, Pavel; Vakulova, Viera; Oppelt, Jan; Bryja, Vitezslav; Doubek, Michael; Mayer, Jiri; Pospisilova, Sarka; Smida, Michal.
Afiliação
  • Kozlova V; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Ledererova A; Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Ladungova A; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Peschelova H; Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Janovska P; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Slusarczyk A; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Domagala J; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Kopcil P; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Vakulova V; Department of Immunology, Medical University of Warsaw, Warsaw, Poland.
  • Oppelt J; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Bryja V; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Doubek M; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Mayer J; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
  • Pospisilova S; Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.
  • Smida M; Department of Internal Medicine - Hematology and Oncology, Medical Faculty of Masaryk University and University Hospital Brno, Brno, Czech Republic.
PLoS One ; 15(3): e0229170, 2020.
Article em En | MEDLINE | ID: mdl-32210425

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Receptores de Antígenos de Linfócitos B / Leucemia de Células B / Linfoma de Células B / Actinas / Antígenos CD20 Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos B / Receptores de Antígenos de Linfócitos B / Leucemia de Células B / Linfoma de Células B / Actinas / Antígenos CD20 Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article